Scott Houlton

CEO Advisory Board Member

Scott Houlton is the CEO of MLM (GPP III) and on the board of Tergus (GPP III).

In 2016, Mr. Houlton joined Clinical Supplies Management (“CSM”) as CEO, completed two European tuck-ins, tripled revenues and in September 2018, led the sale of the business to Clinigen, which resulted in a 4.9x multiple of invested capital and 125% IRR for GPP.  Prior to joining CSM, he was President, Development & Clinical Services and an Officer at Catalent, Inc.

Mr. Houlton graduated cum laude with a Bachelor’s degree in Finance and in International Business from The Ohio State University.

CEO Advisory Board members are consultants and are not exclusive to Great Point.  Amounts paid to CEO Advisory Board members and related expenses are born by fund or portfolio company investors.